Ruthenate(1-), tetrachlorobis(1H-indazole-kappaN2)-, sodium (1:1), (oc-6-11)-
KP1339 is a ruthenium coordination entity that is the sodium salt of tetrachloro[bis(1H-indazole)]ruthenate(III). It is a anticancer drug in clinical development for the treatment of solid tumours. It has a role as an antineoplastic agent and an apoptosis inducer.